Contineum Therapeutics (CTNM) Amortizatization of Intangibles (2023 - 2025)
Contineum Therapeutics has reported Amortizatization of Intangibles over the past 3 years, most recently at $392000.0 for Q4 2025.
- Quarterly results put Amortizatization of Intangibles at $392000.0 for Q4 2025, up 119.57% from a year ago — trailing twelve months through Dec 2025 was $1.1 million (up 23.85% YoY), and the annual figure for FY2025 was $1.1 million, up 23.85%.
- Amortizatization of Intangibles for Q4 2025 was $392000.0 at Contineum Therapeutics, up from -$4000.0 in the prior quarter.
- Over the last five years, Amortizatization of Intangibles for CTNM hit a ceiling of $1.1 million in Q2 2024 and a floor of -$2.0 million in Q4 2024.
- Median Amortizatization of Intangibles over the past 3 years was $338500.0 (2025), compared with a mean of $243083.3.
- Peak annual rise in Amortizatization of Intangibles hit 366.81% in 2024, while the deepest fall reached 291.21% in 2024.
- Contineum Therapeutics' Amortizatization of Intangibles stood at -$512000.0 in 2023, then crashed by 291.21% to -$2.0 million in 2024, then soared by 119.57% to $392000.0 in 2025.
- The last three reported values for Amortizatization of Intangibles were $392000.0 (Q4 2025), -$4000.0 (Q3 2025), and $407000.0 (Q2 2025) per Business Quant data.